Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: Findings from nationally representative longitudinal data from an Asian population

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 579-585

  Khang, Young Ho ^a   Cho, Sung Il ^b   Kim, Hye Ryun ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Inst Hlth and Social Aff   (South Korea)

Author keywords

Asia; Cardiovascular diseases; Diabetes mellitus; Ischaemic heart disease; Korea; Metabolic syndrome; Stroke

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PRIORITY JOURNAL; SOCIAL STATUS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MYOCARDIAL ISCHEMIA; REPUBLIC OF KOREA; RISK FACTORS; STROKE;

EID: 78649738132     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.009     Document Type: Article

References (28)

1. Reaven G.M. Banting Lecutre 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
2. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care 2005, 28:1769-1778.
3. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K., et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004, 164:1066-1076.
4. Galassi A., Reynolds K., He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006, 119:812-819.
5. Ford E.S., Li C.Y., Sattar N. Metabolic syndrome and incident diabetes-current state of the evidence. Diabetes Care 2008, 31:1898-1904.
6. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49:403-414.
7. Li W., Ma D., Liu M., Liu H., Feng S., Hao Z., et al. Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis 2008, 25:539-547.
8. Cheung B.M., Wat N.M., Man Y.B., Tam S., Thomas G.N., Leung G.M., et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 2007, 30:1430-1436.
9. Thomas G.N., Schooling C.M., McGhee S.M., Ho S.Y., Cheung B.M., Wat N.M., et al. Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol (Oxf) 2007, 66:666-671.
10. Ninomiya T., Kubo M., Doi Y., Yonemoto K., Tanizaki Y., Rahman M., et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke 2007, 38:2063-2069.
11. Noda H., Iso H., Saito I., Konishi M., Inoue M., Tsugane S. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Hypertens Res 2009, 32:289-298.
12. Kadota A., Hozawa A., Okamura T., Kadowak T., Nakmaura K., Murakami Y., et al. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000. Diabetes Care 2007, 30:1533-1538.
13. Liu J., Grundy S.M., Wang W., Smith S.C., Vega G.L., Wu Z., et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J 2007, 153:552-558.
14. Chien K., Hsu H., Sung F., Su T., Chen M., Lee Y. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 2007, 194:214-221.
15. Wen C.J., Lee Y.S., Lin W.Y., Huang H.L., Yao C.A., Sung P.K., et al. The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly. Eur J Clin Invest 2008, 38:469-475.
16. Tanomsup S., Aekplakorn W., Sritara P., Woodward M., Yamwong S., Tunlayadechanont S., et al. A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand. Diabetes Care 2007, 30:2138-2140.
17. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II mortality study. Atherosclerosis 2004, 173:309-314.
18. Onat A., Ceyhan K., Başar O., Erer B., Toprak S., Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 2002, 165:285-292.
19. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
20. Lee S.Y., Park H.S., Kim D.J., Han J.H., Kim S.M., Cho G.J., et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Prac 2007, 75:72-80.
21. National Cancer Institute Interactive risk attributable program (IRAP v2. 2). (accessed 17 June 2009). http://dceg.cancer.gov/tools/analysis/irap.
22. Nakanishi N., Takatorige T., Fukuda H., Shirai K., Li W., Okamoto M., et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 2004, 64:59-70.
23. Miura K., Soyama Y., Morikawa Y., Nishijo M., Nakanishi Y., Naruse Y., et al. Comparison of four blood pressure indexes for the prediction of 10-year stroke risk in middle-aged and older Asians. Hypertension 2004, 44:715-720.
24. Walsh T., Donnelly T., Lyons D. Why a sex difference in age-adjusted relationship between height and stroke mortality?. Stroke 2007, 38:e92.
25. Roquer J., Campello A.R., Gomis M. Sex differences in first-ever acute stroke. Stroke 2003, 34:1581-1585.
26. Park J.K., Kim K.S., Kim C.B., Lee T.Y., Lee K.S., Lee D.H., et al. The accuracy of ICD codes for cerebrovascular diseases in medical insurance claims [in Korean]. Korean J Prev Med 2000, 33:76-82.
27. Ryu S.Y., Park J.K., Suh I., Jee S.H., Park J., Kim C.B., et al. The accuracy of myocardial infarction diagnosis in medical insurance claims. Yonsei Med J 2000, 41:570-576.
28. Yang S., Khang Y.H., Harper S., Davey Smith G., Leon D.A., Lynch J. Understanding the rapid increase in life expectancy in South Korea. Am J Public Health 2010, 100:896-903.